Pallarès Natàlia, Videla Sebastià, Carratalà Jordi, Tebé Cristian
Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain.
Basic Clinical Practice, University of Barcelona, Barcelona, Spain.
BMJ Open. 2025 May 30;15(5):e091249. doi: 10.1136/bmjopen-2024-091249.
The aim of this study was to compare in-hospital mortality across waves in patients without and with a ceiling of care at hospital admission.
A multicentre prospective cohort study.
Five tertiary hospitals in Catalonia, Spain, during four waves of the COVID-19 pandemic. Data from the first wave embraced from March to April 2020, second wave from October to November 2020, third wave from January to February 2021 and fourth wave from July to August 2021.
All consecutive adult subjects (older than 18 years old) admitted to any of the five aforementioned centres. All subjects had a confirmed SARS-CoV-2 infection (with a positive PCR test or antigen test) and an overnight hospital stay. Ceiling of care defined as the highest level of care that a patient will receive during medical treatment was assessed at hospital admission for all patients.
In-hospital mortality.
A total of 3982 hospitalised patients without ceiling of care and 1831 hospitalised patients with ceiling of care were included in the analysis. The adjusted ORs of in-hospital mortality in the second wave were 0.57 (95% CI 0.40 to 0.80), in the third 0.56 (95% CI 0.37 to 0.84) and in the fourth 0.34 (95% CI 0.21 to 0.56) compared with the first wave in subjects without ceiling of care. The adjusted OR was significantly lower in the fourth (0.38, 95% CI 0.25 to 0.58) wave compared with the first wave in subjects with ceiling of care.
In patients without ceiling of care, mortality decreased over time, suggesting better disease knowledge and management. In ceiling of care, only fourth wave patients were less likely to die than first wave patients. In a future infectious disease pandemic, it will be a challenge to improve the management of patients with ceiling of care.
本研究旨在比较入院时有无治疗上限的患者在不同疫情波次中的院内死亡率。
一项多中心前瞻性队列研究。
西班牙加泰罗尼亚的五家三级医院,在新冠疫情的四个波次期间。第一波数据收集于2020年3月至4月,第二波于2020年10月至11月,第三波于2021年1月至2月,第四波于2021年7月至8月。
所有连续入住上述五家中心之一的成年受试者(年龄大于18岁)。所有受试者均确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)(PCR检测或抗原检测呈阳性)且在医院过夜。对所有患者在入院时评估治疗上限,即患者在治疗期间将接受的最高护理水平。
院内死亡率。
分析纳入了3982名无治疗上限的住院患者和1831名有治疗上限的住院患者。与第一波相比,无治疗上限的受试者在第二波中的院内死亡校正比值比为0.57(95%置信区间0.40至0.80),第三波为0.56(95%置信区间0.37至0.84),第四波为0.34(95%置信区间0.21至0.56)。与第一波相比,有治疗上限的受试者在第四波中的校正比值比显著更低(0.38,95%置信区间0.25至0.58)。
在无治疗上限的患者中,死亡率随时间下降,表明对疾病的认识和管理有所改善。在有治疗上限的患者中,只有第四波患者比第一波患者死亡可能性更低。在未来的传染病大流行中,改善有治疗上限患者的管理将是一项挑战。